Comments on the Background Document on Propylparaben and Butylparaben in Skin-Applied Leave-On Products Share page: Download Document Issues: OTC Medicines Sunscreen Related Posts Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025 Press Releases and Statements Veteran Scientist & Regulator Joins CHPA’s Senior Management Team May 12, 2025 Press Releases and Statements CHPA Submits Official Comments on Section 232 National Security Investigation of Pharmaceuticals May 8, 2025